Serena Williams described tennis anti-doping testing requirements as grueling and unreasonable in remarks made Sunday ahead of her Wimbledon singles return, saying the demands of the whereabouts system were one of the significant factors that nearly stopped her from coming back to professional competition.
Williams, 44, re-entered the testing pool before she publicly announced her return to tennis, meaning she was already subject to the sport’s no-notice testing protocols during the period leading up to her comeback. She returns to singles competition at Wimbledon on Tuesday when she faces Maya Joint, her first Grand Slam singles match since 2022.
What the rules require and where Williams takes issue
Anti-doping rules administered by the International Tennis Integrity Agency require athletes to submit daily whereabouts information designating a one-hour window during which they guarantee availability for testing. Athletes can also be tested outside that window, and the rules around what constitutes a missed test were the specific source of Williams’ concern.
She said she had not been aware that certain rules had changed and that being unavailable to a tester outside her designated window could still be logged as a missed contact. She described a life that involves running multiple business ventures, international travel, and caring for two children, arguing that the current requirements impose a level of logistical constraint that she considers disproportionate.
The ITIA responded by clarifying that the rules had not in fact changed in recent years. The governing body explained that a tester’s inability to reach an athlete during the designated one-hour window may result in a strike that counts toward the three failures required for a disciplinary charge, while an unsuccessful attempt outside that window does not constitute a strike. Three whereabouts failures within a 12-month period can result in sanctions even without a positive test, a rule that resulted in an 18-month suspension for another player in 2023.
The ITIA also expressed willingness to speak directly with Williams or her representatives to address any confusion about the current requirements.
A broader context that includes a recent high-profile ban
Williams’ comments arrived in the same week that a former Wimbledon champion received a four-year suspension for refusing an out-of-competition test at her home. That case drew attention to the severity of the consequences that athletes face for non-compliance with anti-doping protocols, even when the refusal is attributed to circumstances rather than an intent to conceal prohibited substance use.
Williams was careful to affirm her support for anti-doping testing as a principle and said she had always been transparent about her activities. Her objection was directed at what she described as specific design flaws in the whereabouts system rather than the existence of testing itself. She framed the challenge as one of logistics and communication, particularly during the adjustment period of returning to competition after several years away.
A difficult re-entry into the compliance framework
Returning to the testing pool after years outside professional competition means adapting to protocols that were not part of daily life during the period away. Williams described the process of learning the current rules and establishing the daily reporting habit as an adjustment that proved harder than she anticipated.
Her Wimbledon appearance, which also includes doubles alongside her sister Venus, represents the most significant test yet of whether that adjustment was complete enough to sustain the demands of competing at a Grand Slam. The anti-doping conversation she has opened may continue through the fortnight as the sport processes her return and the broader questions her comments have raised about how the whereabouts system interacts with the realities of athletes who lead complex professional and personal lives.
